Lorin Sasaki
About Lorin Sasaki
Lorin Sasaki serves as the Vice President of Financial Planning and Analysis at Nektar Therapeutics, a position he has held since 2019. He has extensive experience in financial roles, having worked at Nektar Therapeutics since 2008 and previously at Calpine and in SEC Reporting.
Work at Nektar Therapeutics
Lorin Sasaki has been serving as the Vice President of Financial Planning & Analysis at Nektar Therapeutics since 2019. In this role, Sasaki oversees financial planning and analysis functions, contributing to the company's strategic financial decisions. Prior to this position, Sasaki worked in SEC Reporting at Nektar Therapeutics from 2006 to 2008. Overall, Sasaki has accumulated 16 years of experience in various financial roles at Nektar Therapeutics.
Education and Expertise
Lorin Sasaki studied at the University of California, Berkeley, where they completed two separate academic programs. The first period of study was from 1990 to 1994, followed by another program from 2000 to 2004. This educational background has equipped Sasaki with a strong foundation in finance and analysis, which is evident in their professional roles.
Background
Before joining Nektar Therapeutics, Lorin Sasaki worked as a Sarbanes-Oxley Consultant at Calpine from 2004 to 2006. This role involved ensuring compliance with financial regulations and internal controls. Sasaki's career in financial planning and analysis began in 2006, marking the start of a significant tenure in the biotechnology sector.
Professional Experience
Lorin Sasaki has extensive experience in financial planning and analysis, having worked in this capacity since 2008. This includes a leadership role as VP at Nektar Therapeutics and prior experience in SEC Reporting. Sasaki's career reflects a commitment to financial integrity and strategic planning within the biotechnology industry.